Pioglitazone Tablet
Product Images NDC 68071-2373

3 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68071-2373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2373 3)

Pdp (68071 2373 3)
Pioglitazone 30 mg tablets label from NuCare Pharmaceuticals, Inc. The label shows the NDC number 68071-2373-3 and specifies a quantity of 30 tablets. Directions space is provided for dosing frequency. It includes manufacturer information: Tova Czech Industries, s.r.o., Czech Republic, and a warning to keep out of reach of children. The label notes to store at controlled temperature (68-77°F) and includes batch, serial, and expiration placeholders.*
FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of Pioglitazone hydrochloride, showing its molecular framework including aromatic rings, a thiazolidinedione ring, and associated substituents.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line chart showing mean values over a 26-week period for four groups: placebo, 15 mg, 30 mg, and 45 mg doses. The x-axis represents weeks from 0 to 26, and the y-axis represents the mean value. Different colored and shaped markers differentiate the groups according to the legend.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.